$STML STEMLINE THERAPEUTICS INC Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in STEMLINE THERAPEUTICS INC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in STEMLINE THERAPEUTICS INC. Insider overview, share value development, latest insider transactions and email notifications about new events in STEMLINE THERAPEUTICS INC for free.

CIK Number: 0001264587
IRS Number: 450522567
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: STML
Company Address: 750 LEXINGTON AVENUE ELEVENTH FLOOR NEW YORK 10022
Phone number: 212-531-5969

Stemline Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, acquisition, development, and commercialization of novel therapeutics for oncology indications of unmet medical need. Its clinical stage product candidates include SL-401, SL-801, and SL-701. The SL-401, is a targeted therapy directed to the interleukin-3 receptor (CD123) present on a malignancies. The SL-801, is a novel oral small molecule reversible inhibitor of XPO1, that has demonstrated in vivo and in vitro preclinical activity in a solid and hematologic malignancies. The SL-701, is an immunotherapy designed to activate the immune system to attack tumors. The company was founded by Ivan Bergstein on August 8, 2003 and is headquartered in New York, NY.

Market Capitalization: $118.68M
Prev close: $6.20
Average Daily Volume: 325,710
Days Low: $6.00
Year Low: $3.88
Year High: $14.60

STEMLINE THERAPEUTICS INC Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
Bergstein IvanChief Executive Officer2,749,05617,044,147shares bought: 1,036,750 / shares sold: -133,822 STRONG BUYFeb 15 20195 days ago
Gionco DavidChief Accounting Officer170,3451,056,139shares bought: 201,450 / shares sold: -47,775 STRONG BUYFeb 08 201912 days ago
Hoberman KennethChief Operating Officer781,7234,846,683shares bought: 625,450 / shares sold: -132,744 STRONG BUYFeb 08 201912 days ago

View all STEMLINE THERAPEUTICS INC insiders.

STEMLINE THERAPEUTICS INC Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 15 2019STMLSTEMLINE THERAPEUT ...Bergstein IvanChief Executive Off ...SellS10.9834,132374,7692,749,0562.8 M to 2.7 M (-1.23 %)
Feb 08 2019STMLSTEMLINE THERAPEUT ...Hoberman KennethChief Operating Off ...GrantA0.0013,6070795,330781.7 K to 795.3 K (+1.74 %)
Feb 08 2019STMLSTEMLINE THERAPEUT ...Hoberman KennethChief Operating Off ...GrantA0.00135,0710781,723646.7 K to 781.7 K (+20.89 %)
Feb 08 2019STMLSTEMLINE THERAPEUT ...Bergstein IvanChief Executive Off ...GrantA0.0017,00902,783,1882.8 M to 2.8 M (+0.61 %)
Feb 08 2019STMLSTEMLINE THERAPEUT ...Bergstein IvanChief Executive Off ...GrantA0.00284,74802,766,1792.5 M to 2.8 M (+11.48 %)
Feb 08 2019STMLSTEMLINE THERAPEUT ...Gionco DavidChief Accounting Of ...GrantA0.009,0090248,904239.9 K to 248.9 K (+3.76 %)
Feb 08 2019STMLSTEMLINE THERAPEUT ...Gionco DavidChief Accounting Of ...GrantA0.0069,5500239,895170.3 K to 239.9 K (+40.83 %)
Feb 08 2019STMLSTEMLINE THERAPEUT ...Gionco DavidChief Accounting Of ...GrantA0.0015,0000170,345155.3 K to 170.3 K (+9.66 %)
Jan 11 2019STMLSTEMLINE THERAPEUT ...Hoberman KennethChief Operating Off ...SellS10.1513,547137,502646,652660.2 K to 646.7 K (-2.05 %)
Nov 30 2018STMLSTEMLINE THERAPEUT ...Hoberman KennethChief Operating Off ...SellS11.8526,296311,608659,738686 K to 659.7 K (-3.83 %)
Sep 14 2018STMLSTEMLINE THERAPEUT ...Hoberman KennethChief Operating Off ...GrantA0.00175,0000686,034511 K to 686 K (+34.24 %)
Sep 14 2018STMLSTEMLINE THERAPEUT ...Hoberman KennethChief Operating Off ...GrantA0.00100,0000511,034411 K to 511 K (+24.33 %)
Sep 14 2018STMLSTEMLINE THERAPEUT ...Bergstein IvanChief Executive Off ...GrantA0.00200,00002,481,4312.3 M to 2.5 M (+8.77 %)
Sep 14 2018STMLSTEMLINE THERAPEUT ...Bergstein IvanChief Executive Off ...GrantA0.00125,00002,281,4312.2 M to 2.3 M (+5.80 %)
Jun 22 2018STMLSTEMLINE THERAPEUT ...ZUERBLIS KENNETH JDirectorGrantA0.0013,158045,12132 K to 45.1 K (+41.17 %)

View all STEMLINE THERAPEUTICS INC insider transactions.